Olive oil is a rich source of polyphenols, in particular the phenolic acids hydroxytyrosol and tyrosol, and their conjugated forms, such as oleuropein. The bioactivity of these compounds in vivo will depend on the extent of their absorption and metabolism. We have conducted a detailed investigation of the absorption, metabolism and microflora-dependent transformation of olive oil polyphenols at different sites in the gastrointestinal tract. The results show that conjugated forms undergo rapid hydrolysis in acidic gastric conditions, resulting in an increase in the amount of free HT and TYR in the small intestine (475% and 325%, respectively at 30min). These phenols were demonstrated to be absorbed in both human Caco-2 cells (Papp = 2.18±0.37x10 -5 for HT and 5.11±0.59x10 -5 for TYR) and rat segments of the jejunum (Papp = 1.26±0.52x10 -5 for HT and 3.55±0.11x10 -5 for TYR) and the ileum (Papp = 1.41±0.99x10 -5 for HT and 2.91±0.56x10 -5 for TYR). Upon uptake into jejunum or ileum, the compounds underwent various biotransformations via classic phase I/II metabolism pathways. The major metabolites identified were the Omethylated derivatives of HT, O-glucuronides of HT and TYR, and a glutathionylated conjugate of HT. In contrast, there was no absorption of oleuropein in either small intestinal model. However oleuropein was rapidly degraded by the colonic microflora resulting in the formation of HT. Our data indicate that although many of the complex polyphenols present in olive oil (oleuropein and secoiridoids derivatives) are not absorbed, these may be degraded in the GI tract to yield increased amounts of HT and TYR, which may be absorbed and exert biological effects.
Introduction
Olive oil is the principal fat component of the Mediterranean diet, and its consumption has been associated with a lower incidence of coronary heart disease (CHD) and certain cancers [1] [2] [3] [4] . Extra virgin olive oil contains a variety of simple phenolic compounds, such as hydroxytyrosol (HT), tyrosol (TYR), and their secoiridoid derivatives, such as oleuropein (OL) and its aglycone form.
These compounds, together with other components, such as tocopherols, contribute towards the protection of olive oil against auto-oxidation, and have been demonstrated to exert many potentially beneficial biological effects both in vitro and in vivo [5] [6] [7] [8] [9] [10] [11] . However, the biological properties of these compounds in vivo will depend on the extent of their absorption and metabolism. In vivo studies have been performed to investigate the bioavailability of olive oil polyphenols by measurement of their excretion in urine following administration [12] [13] [14] [15] . It has been reported that hydroxytyrosol and tyrosol levels in urine increase after olive oil administration, and that these compounds were primarily excreted as O-glucuronidated conjugates [15] [16] [17] . Hydroxytyrosol may also be O-methylated in vivo, and homovanillic acid and homovanillyl alcohol have been measured in human and animal studies in plasma and urine after olive oil ingestion [12, 16, 18, 19] . In addition, human studies conducted in healthy and ileostomy patients fed with polyphenols have show that ingested olive oil phenols were absorbed in healthy and ileostomy subjects, which indicates that most, if not all, are absorbed in the small intestine [20] . However, only few data exist for the absorption and metabolism of olive oil polyphenols in the small intestine, and there are little or no data for their stability in the stomach or their biotransformation in the colon. For example, Manna et al. [21] reported that HT is absorbed by passive diffusion in Caco-2 cells but there are no data on the specific absorption/metabolism of other olive oil polyphenols in the small intestine.
The aim of this study was to investigate the absorption, subsequent biotransformation and potential modification of a range of olive oil polyphenols (including oleuropein and secoiridoid derivatives) in the gastrointestinal tract. In particular we focus on their decomposition in the stomach, their absorption and metabolism in the small intestine and their biotransformation by the microflora present in the large intestine. Knowledge of the detailed biotransformation of olive oil 4 polyphenols in the gastrointestinal tract will provide important information regarding potential bioactive components in vivo.
Materials and Methods

Materials.
The polyphenolic mixture was obtained by processing extra virgin olive oil by methanol/water extraction as previously described by Caruso et al. [17] . The Caco-2 cell line was obtained from Incubation of polyphenolic fraction with simulated gastric juice.
In order to obtain information about the breakdown susceptibility of conjugated forms, polyphenolic fraction (1mg/ml) was submitted to acidic hydrolysis under conditions similar to the gastric environment (water acidified with HCl to reacha pH=2) and incubated at 37ºC for 30min, 1h, 2h and 4h. After incubation, samples were analyzed by HPLC detection (see later).
Transport and metabolism experiments in the perfused rat intestinal model.
Transport and metabolism experiments were conducted using the in vitro intestinal preparation of Fisher and Gardner [22, 23] in which the lumen of isolated intestine is perfused with a segmental flow (defined as perfusion of buffer interspersed with bubbles of the gas mixture) of bicarbonate buffer (pH 7.4) equilibrated with 95% O2:5% CO2 and containing 28 mM glucose. Cell Culture.
Sub-cultures of the Caco-2 cells were grown in T-75 culture flasks and passaged with a trypsinversene solution. Cells were cultured in DMEM supplemented with 20% FBS, 1% non essential amino acids, 2mM L-glutamine, penicillin (100 units/ml), and streptomycin (100 g/ml) at 37°C in 5%
CO2.
Transport experiments in the human Caco-2 cell culture model. 
Synthesis of hydroxytyrosol-glutathione conjugate
Hydroxytyrosol-glutathione conjugate was prepared by a method similar to that previously described by Spencer et al [24] for catecholamine conjugates, with some modifications. GSH (10mM) and mushroom tyrosinase (2000 units/ml) were incubated in sodium acetate buffer (20 mM), pH 6.5, at 25°C (total volume of 10ml) before the drop-wise addition of hydroxytyrosol (10mM) under constant stirring for 1h. To stop the reaction the sample mixture was acidified with 0.5% HCl 5M and after centrifugation the supernatant was collected for HPLC analysis.
Colonic microflora fermentation: batch culture.
The composition of the basal growth medium, per liter, was: peptone (2g), yeast extract (2g), Tween
resazurin (1mg), and distilled water to volume. The medium was dispensed into the fermentation vessels and autoclaved at 121ºC for 15 min. Post-autoclaving, the hot medium was purged with oxygen-free nitrogen at the rate 15 ml/min. Fecal slurry of 10% (w/v) feces was prepared by homogenizing a stool sample with anaerobic phosphate-buffered saline (0.1 M, pH 7.0) in a 7 stomacher. The slurry was sieved to remove particulate material. Fecal donors were aged 20 to 40 years, had no history of gastrointestinal disease, and had not taken antibiotics in the 6 months prior to donation. Samples were processed within 10 min of defecation. The fermentation volume was 150 ml. Each batch culture (substrate fermentation and control fermentations) consisted of 90% basal growth medium and10% fecal slurry. Oleuropein (1mM) was added to the vessel and culture pH was maintained at 6.8-7.0 throughout the incubation. Continuous monitoring of pH and automatic addition of alkali (0.5M NaOH) and acid (0.5M HCl) was automated by use of an Electrolab pH controller. Cultures were incubated at 37ºC by a heated water jacket, continuously purged with oxygen-free nitrogen (15 ml/min), and mixed on a magnetic stirrer. The fermenters were made of glass and had sampling ports to remove culture medium for analysis through the incubations, at time 0, 4h, 8h, 12h, 24h and 48 h. Following sampling from fermentation vessels, the suspension was spun for 5 min at 13,000xg. The resultant supernatant was used for HPLC analysis. The experiment was carried out in duplicate and using 3 different fecal donors.
HPLC analysis.
HPLC analysis to measure compound and metabolite concentrations was carried out with a Hewlett-Packard 1100 series liquid chromatograph (Hewlett-Packard, Palo Alto, CA) equipped with a diode array detector linked to the HP ChemStation Software system. Samples were analyzed by reverse-phase HPLC using a Nova-Pak C18 column (4.6 * 250 mm) (Waters Company) with 4μm particle size. The temperature of the column was maintained at 30°C. The mobile phases consisted of a mixture of aqueous methanol 5% in 0.1% hydrochloric acid 5M (A) and a mixture of aqueous acetonitrile 50% in 0.1% hydrochloric acid 5M (B) and were pumped through the column at 0.7 ml/min. The following gradient system was used (min/% B): 0/5, 5/5, 40/50, 55/100, 59,9/100, 60/5, whit 10min post-run for both compound and metabolite detections. The eluent was monitored by photodiode array detection at 280nm and spectra of products obtained over the 200^600 nm range.
Calibration curves of the compounds were constructed using authentic standards (0.1 to 100 M) and in each case were found to be linear with correlation coefficients of >0.995. 
Results
Incubation of polyphenolic fraction with simulated gastric juice.
Although the gastric conditions in vivo are complex with the food matrix affecting the precise pH, the incubation of polyphenols at gastric pH can give us information about the stability of polyphenols in the gastric environment. An olive oil polyphenolic fraction (1mg/ml) was incubated in water acidified with HCl to reacha pH=2 at 37ºC for up to 4h to simulate conditions in the stomach, and the fig. 2A and B) . Similarly, after perfusion with tyrosol, the parental compound and two new peaks were observed in the serosal fluid of both gut segments ( fig. 2C and D) . Both new peaks disappeared after glucuronidase treatment, with a subsequent increase in tyrosol and a new peak, indicating that a glucuronide of tyrosol and another glucuronide metabolite were present. This new peak had similar spectral properties as tyrosol, but it remains to be identified. Figure 3 indicates that both HT and TYR are absorbed in the parental form to a greater extent in the ileum than in the jejunum ( fig. 3A and B) , which may reflect enzymatic profiles in these tissues. The perfusion of the polyphenolic fraction also resulted in the transfer of compounds, tyrosol and hydroxytyrosol, and lead to the formation of glucuronide conjugates and homovanillyl alcohol ( fig. 2E and F and fig. 3C ). HPLC chromatograms did not reveal the presence of other metabolite resulting from the polyphenolic extract perfusion.
We calculated the apparent permeability coefficients for hydroxytyrosol and tyrosol in both jejunum [26] . Therefore, we propose that both HT and TYR are very well absorbed in the small intestine.
Colonic microflora fermentation: batch culture
Previous studies have shown that oleuropein is stable in human gastric juice and duodenal fluid [20] . Based on the fact that our data demonstrate that oleuropein is not absorbed or metabolized in the small intestine, it is likely to reach the large intestine where it will be subject to degradation by the colonic microflora. To gain insight into the colonic microflora-mediated biotransformations we utilized a anaerobic fermentation system. Anaerobic suspensions of human colonic micro flora were incubated with OL, the supernatants were collected at various time points and analyzed by HPLC in order to characterize and to quantify OL and OL-derived microfloral metabolites. A representative HPLC chromatogram of the ferment is shown in figure 7 (panel A) . The results demonstrate that oleuropein was quickly and extensively degraded resulting in the formation of 3 compounds detected at 11.6min, 36.8min and 53.9min RT ( fig.7A ). Based on the RT, the UV spectrum, and confirmed by comparisons with an authentic standard, the peak at 11.6min was identified as hydroxytyrosol. The two other metabolites remain tp be identified. Figure 7B 
Discussion
Despite the substantial body of evidence linking the in vitro properties of olive oil polyphenols to the health benefits associated with olive oil consumption, there are limited data on absorption and metabolism. In order to obtain more detailed information about their mechanism of action in vivo, it is essential to know in which form olive oil polyphenols are when they reach the circulation and ultimately the tissues. Presently, the vast majority of information in the literature is based on analysis of blood and urine samples in animal and human studies [12-14, 16, 17, 30-33] . However, these studies do not differentiate between the contribution of gastrointestinal metabolism and overall absorption and biotransformation of olive oil polyphenols. We observed significant nonenzymatic hydrolysis of the conjugated forms olive oil polyphenols under conditions similar to those expected during transit through the stomach in vivo. Although conditions in vivo are more complex than in the model used here, with the food matrix affecting the precise pH, it is highly likely that the gastric environment achieves a pH of at least 2-3 for a period around 30-minutes, i.e. in order that sufficient enzymatic protein degradation may occur (pepsin). Therefore, we suggest that under such conditions the stability of complex olive oil polyphenols may be affected and could result in a significant increase in the amount of HT and TYR that arrives in the small intestine (4.75 and 3.25 times respectively after 30min) via the pyloroduodenal junction. In this case, higher amounts of HT and TYR may be presented for absorption in the jejunum and ileum than would be expected.
Our absorption studies agree with previous investigations which have shown the presence of HT and TYR glucuronides in urine following ingestion of olive oil polyphenols [12, 13, 17, 31, 33] . We 13 detected HT, TYR, homovanillyl alcohol and their glucuronides in the rat small intestine model, which agreed with experiments performed in Caco-2 cells, except that no glucuronides were detected in the cellular model. This is presumably because Caco-2 cells do not possess UDPglucuronosyl transferase activity due to their colonic origin [34] . We stress that caution should be used when interpreting absorption and metabolism data from this cell model as it could underestimate the true level of absorption of a polyphenol, especially that of the glucuronide conjugates. Similarly, use of the isolated rat small intestine model may not generate other potential human metabolites. For example, the results obtained with Caco-2 cells for hydroxytyrosol show that the compound is also glutathione conjugated, which is not the case in the rat small intestinal segment model. As mentioned, these differences reflect different characteristics and enzymatic profile which exist between Caco-2 cells and small intestine segments, and need to be considered when interpreting all polyphenol absorption data. Indeed the Caco-2 model has been considered a suitable model for intestinal CYP3A4 mediated first pass metabolism, but not necessarily for UGT mediated glucuronidation [35, 36] . It should also be noted that not all intestinal drug metabolizing enzymes are present in this cell line, even though Caco-2 cells have been extensively used in studies of uptake and metabolism of flavonoids [21, 37, 38] .
Data from the two models give us a more complete understanding of how these compounds are absorbed and metabolized in humans. We have identified for the first time a glutathione conjugate of hydroxytyrosol generated in Caco-2 cells. This metabolite may be formed either enzymatically via the action of glutathione S-transferase or non-enzymatically via oxidative metabolism of HT followed by its reaction with GSH [39] . Conjugations with thiols, such as glutathione, represent a major target for quinones, and the detoxification of quinones by GSH is generally considered to be cytoprotective. In addition, thiol conjugates of phenolics may be major bioactive forms in vivo and may contribute to positive health effects. We show that the majority of HT and TYR is absorbed, and underwent O-methylation (HT), glucuronidation (HT and TYR) and glutathionyl conjugation (HT)
in the small intestine. O-methylation and glucuronidation process are common metabolic pathways in the small intestine for plant derived phenolic acids [23] and in agreement with previous studies [12, 16, 19] showing the presence of these metabolites in plasma and urine after oral administration. Furthermore, in our experiments we did not reveal the presence of homovanillic acid, 3-hydroxy-4-methoxy phenylacetic acid, 2-(3,4-dimethoxyphenyl)-ethanol and sulfateconjugate metabolites, hydroxytyrosol metabolites found in rat urine [19] , so we can presume that these metabolites are formed after transport across the small intestine, most probably in the liver.
Oleuropein was not absorbed in the parental form in the small intestine and was not degraded under acidic conditions. Consequently it is likely to reach the large intestine, where it may be subjected to rapid degradation by the colonic microflora. Three major degradation products were produced by the microflora, one of them identified as being HT. Metabolism by colonic bacterial species may have the effect of increasing overall HT bioavailability, as released HT can be absorbed in the colon, as has been shown for other phenolic acids [28, 29] . In addition, oleuropein itself may possess potential prebiotic properties if bacterial groups, such as Bifidobacteria and
Lactobacillus, may utilize it as a carbon source, but others such as Clostridium and E. coli cannot.
Due to the rapid rate of oleuropein fermentation in the gut model, future investigations are planned to investigate whether oleuropein fermentation by colonic microflora can result in potential 'prebiotic' changes in microbial composition.
Although metabolic processes in the small intestine may act to decrease the bioavailability and consequently the biological effects of native polyphenols, such as hydroxytyrosol and tyrosol, their resultant metabolites may be capable of exerting biological effects in vivo: For example Tuck and al. [19] reported that the radical scavenging potency of homovanillyl alcohol was similar to hydroxytyrosol and that of the 3-O-glucuronide conjugate was more potent when screened in an in vitro assay system. Whilst there has been a major focus on the antioxidant properties, there is an emerging evidence that plant derived polyphenols, in particular flavonoids, and their in vivo metabolites can also modulate the activity of specific proteins involved in intracellular signaling pathways [40] . Many investigations indicate that flavonoids may interact within the mitogenactivated protein kinase (MAP kinase) signaling pathway [41, 42] and it is possible that through oxidative mechanisms phenolic acids may act in the same way. As hydroxytyrosol, tyrosol and their metabolites are relatively well absorbed in the small intestine compared to flavonoids, future investigations will center on their potential cellular actions, as has been shown for other plant derived polyphenol metabolites [39, 41, [43] [44] [45] .
Our study provides additional information regarding the breakdown of complex olive oil polyphenols in the GI tract, in particular the stomach and the large intestine. We provide novel evidence for the breakdown of complex secoirids derivatives of olive oil polyphenols in a physiological time frame in the stomach. This gastric biotransformation effectively increases the relative amount of hydroxytyrosol and tyrosol entering the small intestine. We also identify a new metabolite of hydroxytyrosol (glutathione conjugated) and highlight the importance of comparing the transfer and metabolism of polyphenols in two different models of the small intestine. Finally, we show for the first time that although oleuropein (a major olive oil polyphenol) is not absorbed in the small intestine it is rapidly degraded by the colonic microflora to yield hydroxytyrosol, which may then be absorbed. 
